First-line treatment selection and early monitoring patterns in chronic phase-chronic myeloid leukemia in routine clinical practice: SIMPLICITY-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

First-line treatment selection and early monitoring patterns in chronic phase-chronic myeloid leukemia in routine clinical practice: SIMPLICITY

Published:2017-09-25 Issue:11 Volume:92 Page:1214-1223
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Goldberg Stuart L.¹^ORCID,Cortes Jorge E.²,Gambacorti-Passerini Carlo³,Hehlmann Rüdiger⁴,Khoury H. Jean⁵,Michallet Mauricette⁶,Paquette Ron L.⁷,Simonsson Bengt⁸,Zyczynski Teresa⁹,Foreman Aimee¹⁰,Abruzzese Elisabetta¹¹,Andorsky David¹²,Beeker Aart¹³,Cony-Makhoul Pascale¹⁴,Hansen Richard¹⁵,Lomaia Elza¹⁶,Olavarria Eduardo¹⁷,Mauro Michael J.¹⁸^ORCID

Affiliation:

1. John Theurer Cancer Center, Hackensack University Medical Center; Hackensack New Jersey

2. The University of Texas, MD Anderson Cancer Center; Houston Texas

3. University of Milano Bicocca, San Gerardo Hospital; Monza Italy

4. Universität Heidelberg; Mannheim Germany

5. Winship Cancer Institute of Emory University; Atlanta Georgia

6. Centre Hospitalier Lyon-Sud; Pierre-Bénite France

7. UCLA Medical Center; Los Angeles California

8. Uppsala Universitet; Uppsala Sweden

9. Bristol-Myers Squibb; Princeton New Jersey

10. ICON plc; San Francisco California

11. S. Eugenio Hospital; Rome Italy

12. Rocky Mountain Cancer Centers; Boulder Colorado

13. Spaarne Hospital; Hoofddorp The Netherlands

14. Centre Hospitalier Annecy-Genevois; Pringy France

15. IDGGQ, Institut für med; Kaiserslautern Germany

16. Federal Almazov North-West Medical Research Centre; St Petersburg Russia

17. Hammersmith Hospital, Imperial College London; London United Kingdom

18. Memorial Sloan-Kettering Cancer Center; New York City New York

Funder

BMS

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.24887/fullpdf

Reference47 articles.

1. Educational session: managing chronic myeloid leukemia as a chronic disease;Hochhaus;Hematol Am Soc Hematol Educ Program.,2011

2. Adherence to BCR-ABL inhibitors: issues for CML therapy;Jabbour;Clin Lymphoma Myeloma Leuk.,2012

3. Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib;Gambacorti-Passerini;J Natl Cancer Inst.,2011

4. Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy;Huang;Cancer.,2012

5. Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials;Sasaki;Lancet Haematol.,2015

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leucemia mieloide crónica: ¿Es posible la remisión libre de tratamiento fuera de ensayos clínicos?;Revista Hematología;2024-01-26

2. Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherence;Blood Advances;2023-07-03

3. Real-world Management of CML: Outcomes and Treatment Patterns;Current Hematologic Malignancy Reports;2023-07-03

4. Real-world Imatinib Mesylate Treatment in Patients with Chronic Myeloid Leukemia: The Importance of Molecular Monitoring and the Early Molecular Response;Annals of Hematology;2023-04-13

5. Adherence to quality indicators in chronic myeloid leukemia care: results from a population-based study in The Netherlands;Leukemia & Lymphoma;2022-11-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3